Biophore ramps up Made-In-India Favipiravir production for Covid-19
Biophore has received the DCGI license to manufacture the API in India and has been cleared for export as well
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bharat Biotech starts human trials for Covaxin, India’s first COVID-19 vaccine
The company had earlier received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human…
Operation Warp Speed to start making COVID-19 vaccine by end of summer, says U.S. official
He added that the administration is already working with companies to equip and outfit manufacturing facilities and acquire raw…
Cipla receives final approval for generic version of Shire’s Firazyr
Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and…
Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’…
The market is “desperate to latch onto any positive developments in the vaccine field,” JP Morgan analyst Cory Kasimov said in a…
Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe…
DoP to finalise guidelines to select locations of three bulk drug parks and four med devices parks:…
Govt of Punjab shows interest in extending support for the development of bulk drugs park in the State
Institute of Life Sciences, Odisha establishes in vitro cultures of COVID-19
This could help to identify drug targets, formulations for the treatment of COVID-19
Mumbai, Thane to get 60 per cent of Maharashtra’s remdesivir stock
It is likely that Cipla and Hetero Healthcare will supply 9000 vials and 12500 vials of remdesivir, respectively, to the State…
CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months
The DCGI has taken this decision after considering the current situation in the country and the need for uninterrupted supply of…